Raymond James & Associates’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$349K Sell
16,389
-4,344
-21% -$92.5K ﹤0.01% 3302
2024
Q2
$396K Buy
20,733
+2,220
+12% +$42.4K ﹤0.01% 3183
2024
Q1
$357K Sell
18,513
-10,447
-36% -$201K ﹤0.01% 3256
2023
Q4
$603K Buy
28,960
+1,125
+4% +$23.4K ﹤0.01% 2823
2023
Q3
$600K Sell
27,835
-2,384
-8% -$51.4K ﹤0.01% 2763
2023
Q2
$723K Sell
30,219
-105
-0.3% -$2.51K ﹤0.01% 2667
2023
Q1
$645K Sell
30,324
-10,229
-25% -$217K ﹤0.01% 2742
2022
Q4
$663K Buy
40,553
+12,638
+45% +$207K ﹤0.01% 2683
2022
Q3
$392K Sell
27,915
-149
-0.5% -$2.09K ﹤0.01% 2996
2022
Q2
$700K Sell
28,064
-376
-1% -$9.38K ﹤0.01% 2681
2022
Q1
$958K Buy
28,440
+7,470
+36% +$252K ﹤0.01% 2618
2021
Q4
$681K Sell
20,970
-34,851
-62% -$1.13M ﹤0.01% 2866
2021
Q3
$1.95M Buy
55,821
+8,339
+18% +$292K ﹤0.01% 2117
2021
Q2
$1.97M Buy
47,482
+36,681
+340% +$1.52M ﹤0.01% 2104
2021
Q1
$398K Sell
10,801
-5,717
-35% -$211K ﹤0.01% 3152
2020
Q4
$686K Buy
16,518
+182
+1% +$7.56K ﹤0.01% 2578
2020
Q3
$694K Sell
16,336
-41,543
-72% -$1.76M ﹤0.01% 2401
2020
Q2
$2.51M Sell
57,879
-5,706
-9% -$247K ﹤0.01% 1587
2020
Q1
$2.09M Buy
63,585
+52,428
+470% +$1.72M ﹤0.01% 1544
2019
Q4
$411K Buy
11,157
+597
+6% +$22K ﹤0.01% 2857
2019
Q3
$355K Sell
10,560
-1,461
-12% -$49.1K ﹤0.01% 2882
2019
Q2
$472K Buy
12,021
+6,285
+110% +$247K ﹤0.01% 2704
2019
Q1
$232K Buy
+5,736
New +$232K ﹤0.01% 3122
2018
Q4
Sell
-70,026
Closed -$3.6M 3482
2018
Q3
$3.6M Buy
70,026
+571
+0.8% +$29.4K 0.01% 1425
2018
Q2
$3.5M Sell
69,455
-3,378
-5% -$170K 0.01% 1397
2018
Q1
$3.72M Buy
72,833
+3,389
+5% +$173K 0.01% 1318
2017
Q4
$3.65M Sell
69,444
-1,708
-2% -$89.7K 0.01% 1311
2017
Q3
$3.48M Buy
71,152
+63,470
+826% +$3.1M 0.01% 1275
2017
Q2
$371K Sell
7,682
-9,490
-55% -$458K ﹤0.01% 2577
2017
Q1
$723K Sell
17,172
-675
-4% -$28.4K ﹤0.01% 2165
2016
Q4
$753K Buy
17,847
+5,999
+51% +$253K ﹤0.01% 2095
2016
Q3
$519K Buy
11,848
+2,210
+23% +$96.8K ﹤0.01% 2260
2016
Q2
$420K Buy
9,638
+465
+5% +$20.3K ﹤0.01% 2197
2016
Q1
$404K Buy
+9,173
New +$404K ﹤0.01% 2160